ILIB对食管癌放疗增敏的相关性研究  

Clinical study on the correlation between ILIB and its enhancing radiosensitivity in esophageal carcinoma

作　　者：庄梅生[1] 陈斌[1] 王继宇[1] 

机构地区：[1]揭阳市人民医院放疗科,522000

出　　处：《国际医药卫生导报》2009年第11期22-24,共3页International Medicine and Health Guidance News

摘　　要：目的采用低能量氦-氖激光血管内照射（ILIB）对机体免疫、血液流变指标进行研究及生存率进行统计。方法采用随机对照分组,前瞻观察ILIB组与对照组放射治疗前、后免疫及血液各项指标进行观察对比、及生存率进行对比。结果在放疗中血流流变性质,免疫功能显著改善,1至3年生存率有明显提高。结论ILIB对食管癌放疗增敏有明显的意义。Objective To investigate the effects of low-energy He-Ne intravascular laser irradiation on blood （ILIB） on the immune function, hemorrheology and survival rate of patients with esophageal carcinoma. Methods 180 patients with esophageal carcinoma were randomly divided into control group （90 cases, treated by single radiotherapy） and sensitization group （90 cases, treated by radiotherapy plus ILIB）. The immune function, hemorrheology and survival rate of two groups were observed and compared before and after radiation therapy. Results compared to control group, the index of the immune function and hemorrheology and survival rate of patients were significantly improved, and the 1-3 year cumulative survival rate was obviously increased. Conclusions ILIB has an important clinical significance for enhancing radiosensitivity in esophageal carcinoma.

关 键 词：低能量He-Ne激光血管内照射(ILIB) 食管癌 增敏 

分 类 号：R735[医药卫生—肿瘤]